PEROZIN ApS: Financial statements 2023
CVR: 29183910
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
PEROZIN ApS (CVR 29183910) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,634,406 and a net result of DKK 904,208 compared with DKK 999,710 the year before. That is a decrease of 19.1% compared with the year before. Equity in the 2023 report amounted to DKK 7,881,821. The solvency ratio was 92.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,634,406
- Profit/Loss
- DKK 904,208
- Equity
- DKK 7,881,821
- Total Assets
- DKK 8,505,931
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.6 mio. | 904 t. | 7.9 mio. | 1 |
| 2022 | - | 2 mio. | 1000 t. | 7 mio. | 2 |
| 2020 | - | 950 t. | 14 t. | 5.6 mio. | 3 |
| 2019 | - | 2.1 mio. | 868 t. | 5.5 mio. | - |
| 2018 | - | 1.3 mio. | 226 t. | 4.6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout PEROZIN ApS
PEROZIN ApS is a Danish company of the type Anpartsselskab based in Haslev, founded in 2005. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Gerard Gerner Hansen. The company is owned by GEBAL Holding ApS, Barghoth Ala Hasan Ali and Ehsan Ahmed Mousa Abdalla Elfarra. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 2,799,719 and a net result of DKK 1,026,124 compared with DKK 736,080 the year before. Equity in the 2025 report amounted to DKK 9,644,024.